Consistent with the ICI analysis on the surface of cancer cells, AccuTOX® combined with anti-CD47 (yellow line) was substantially superior than AccuTOX® alone (green line) at inhibiting EL4 T-cell lymphoma growth (Fig. 2B). Here, CD47 is linked to cancer.